Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,856 active trials61 approved drugs307 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,398 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06766266 | Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment | recruiting | Phase 1 | 18 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06883409 | Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer | recruiting | N/A | 33 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Mar 26, 2025 |
| clinicaltrials |
| NCT06893861 | Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer | recruiting | — | 3,100 | National Cancer Institute, NaplesOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06894628 | Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation | recruiting | — | 103 | Regina Elena Cancer InstituteOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06890858 | A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer | recruiting | Phase 2 | 20 | Zhejiang Provincial People's HospitalOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT06823427 | 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma | recruiting | Phase 2 | 60 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06889623 | Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer(HIGCrecur) | recruiting | N/A | 72 | Changhai HospitalOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04794777 | Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer | recruiting | Phase 3 | 450 | Stefan CarlssonOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05169112 | Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy | recruiting | Phase 3 | 72 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06078514 | Sexual Function and Quality of Life After LEEP: a Prospective Multi-Center Study(SEQUEL) | recruiting | — | 1,000 | Tampere University HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06288360 | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC | recruiting | Phase 2 | 40 | Tongji HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06870903 | Comparison of Transvaginal Paracervical and Transperitoneal Approaches in Lymphadenectomy During v-NOTES Surgery for Patients Diagnosed With Endometrial Cancer(ENDONOTE) | recruiting | N/A | 52 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05229679 | HPV-based Screening Among Women 23-29 Years of Age | recruiting | N/A | 180,000 | Karolinska InstitutetOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05640700 | Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia | recruiting | — | 90 | Hadassah Medical OrganizationOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05728957 | Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors(BIOPSy) | recruiting | — | 100 | Loyola UniversityOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06714916 | Optimising Renal Tumour Management Through Artificial Intelligence Modules | recruiting | — | 2,100 | Shao PengfeiOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06883539 | A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. | recruiting | Phase 1 | 24 | LaunXP Biomedical Co., Ltd.INDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06641635 | Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer | recruiting | Phase 3 | 440 | Peking Union Medical College HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06735287 | A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer | recruiting | N/A | 60 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT04008563 | Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium(B-FiERCE) | recruiting | N/A | 36 | University Health Network, TorontoOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06269809 | Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial(TACROM) | recruiting | N/A | 82 | Universitaire Ziekenhuizen KU LeuvenOTHER | 3 | Mar 14, 2025 | clinicaltrials |
| NCT06763354 | The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging | recruiting | N/A | 20 | RenJi HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06877065 | Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Identification of Risk Factors for Aggressive Disease.(FEST-CC) | recruiting | — | 60 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06878027 | Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool | recruiting | — | 100 | Regina Elena Cancer InstituteOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04100174 | Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy(fBTsRT) | recruiting | Phase 2 | 150 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06260358 | Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging(STRECC) | recruiting | — | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06324175 | Spatial Radiogenomics of Ovarian Cancer(CO-MOULD) | recruiting | — | 24 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06331130 | Mesenteric Infiltration in Ovarian Cancer(MIO) | recruiting | — | 510 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06560112 | An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer | recruiting | Phase 2 | 172 | AkesoINDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06635837 | Prospective Evaluation of the Role of MRI in Ovarian Masses During Pregnancy(PROM-P) | recruiting | — | 60 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06652607 | PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer(PSA-DEEP02) | recruiting | — | 152 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT06093438 | Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer | recruiting | Phase 1 / Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06863090 | In Vivo Dosimetry for Brachytherapy Study | recruiting | — | 20 | East and North Hertfordshire NHS TrustOTHER_GOV | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06866782 | European Registry of Next Generation Imaging in Advanced Prostate Cancer(RING) | recruiting | — | 600 | Fundacio PuigvertOTHER | 8 | Mar 11, 2025 | clinicaltrials |
| NCT03987633 | EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality(EMPOWER) | recruiting | — | 200,000 | Future Genetics LimitedOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT04196257 | BP1001-A in Patients With Advanced or Recurrent Solid Tumors | recruiting | Phase 1 | 50 | Bio-Path Holdings, Inc.INDUSTRY | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06475261 | Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy | recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06863844 | The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor(PROCURO) | recruiting | — | 210 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06863857 | Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer(SPECTRE) | recruiting | — | 50 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance(SOCCER-P) | recruiting | Phase 2 | 124 | Korea University Guro HospitalOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT06085404 | Patients Derived Organoids in Ovarian Cancer(PICTURE) | recruiting | N/A | 48 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06446401 | The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer(Lead4Care) | recruiting | — | 1,400 | Uppsala UniversityOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06565247 | Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation | recruiting | Phase 3 | 60 | Region VästerbottenOTHER_GOV | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06203106 | NYSCF Scientific Discovery Biobank | recruiting | — | 10,000 | New York Stem Cell Foundation Research InstituteOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT00005095 | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention | recruiting | — | 6,000 | Northwestern UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06844136 | ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients(ChemoINtel) | recruiting | — | 100 | Pierian BiosciencesINDUSTRY | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06783829 | A Study of SHR-4394 Injection in Subjects With Prostate Cancer | recruiting | Phase 1 | 240 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06850545 | Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer(KuPSMALu) | recruiting | — | 150 | Kuopio University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06845982 | Anatomopathological Evaluation of a New Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease(EFIBIA) | recruiting | N/A | 250 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 25, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Mar 26, 2025source: clinicaltrials